About | ASPIVIX

ASPIVIX, because we believe that women deserve gentle and modern care

Meet ASPIVIX's Mission


Next-generation surgical instrument designed for gynecology. Innovation makes our lives much easier than ever before. But when it comes to areas that specifically impact women, we are years or even centuries behind. Women’s care in gynecology is one of these areas. There hasn’t been true innovation in instruments commonly used in gynecology for centuries.

We invented ASPIVIX because we believe that women deserve a modern and gentle method to grasp and stabilize the cervix, a very intimate part of the female body. Stabilization of the cervix is required for many procedures that need uterus access such as the insertion of an Intrauterine Device for contraception or an Intrauterine Insemination for reproductive medicine.

Women deserve a next generation surgical instrument, with a gentle and soft suction pad in lieu of sharp jaws harming the cervix tissue. Women deserve to choose contraception without fear as well as visit a gynecologist without stress and leave without pain.

Who we are


The people behind ASPIVIX share the same ambition to innovate women’s care. We’re driven by our passion to change the game for millions of women who endure the pain of obsolete gynecological practices, every year. No doubt it is possible! Every single one of us is contagiously motivated about bringing Aspivix to women and caregivers around the world.

Mathieu Horras

Chief Executive Officer

Julien Finci

Chief Technology Office

David Finci

Chief Medical Officer

History


The idea of development germinated after Dr. David Finci, Medical Doctor, certified FMH in Gynecology, observed that, currently, there is no alternative to the tenaculum. In the private office in Geneva, Dr. David Finci had to use tenaculum on the daily basis for procedure requiring the access to the uterine cavity by grasping and stabilizing the cervix (the entrance of the uterus). The tenaculum has been used and has remained unmodified for centuries. It still features stainless-steel jaws ending in sharp inward-pointing hooks.

To achieve its grasping effectiveness, a tenaculum obviously causes pain, is traumatic, and often triggers bleeding and sometimes iatrogenic lesions of the cervix.

Besides the fact that Dr. David Finci was uncomfortable every time he had to afflict the pain to the patient, this procedure implied many unnecessary steps due to the use of tenaculum (i.e.: anesthesia, patients were instructed to cough, closing the tenaculum completely without “audible clicks” to reduce anxiety, stop the bleeding, and many conversations to reassure the patients).

Dr. David Finci and his brother, Julien Finci, EPFL engineer and project leader in new technology development for medical devices, decided to investigate potential alternatives to the tenaculum. After a few months of research and investigation, they built their first prototype. It was the first premise of Aspivix. With my support, Mathieu Horras, MBA insead and Global director for Product Management and Marketing in Medtech, we co-founded and incorporated Aspivix in July 2015.

Peter Drucker said that “The best way to predict the future is to create it.” This sentence is at the very heart of our inspiration and motivation. Launching Aspivix is driven by our willingness to fill a gap in gynecology practice and changing the game for millions of women bearing the pain of obsolete practices every year. Our vision is to create a new workplace in Switzerland to shape the future of women’s care through innovation.

Get in touch


GLOBAL HEADQUARTERS

ASPIVIX SA

Chemin du Closel 5

1020 Renens

Switzerland